XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.25.1

Goodwill and Other Intangible Assets | 3 Months Ended
--- | ---
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | NOTE C – GOODWILL AND OTHER INTANGIBLE ASSETS The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:
| As of March 31, 2025 |  | As of December 31, 2024
(in millions) | Gross Carrying Amount |  | Accumulated Amortization/ Write-offs |  | Gross Carrying Amount |  | Accumulated Amortization/ Write-offs
Technology-related | $ | 14,406 |  |  | $ | (8,799) |  |  | $ | 14,327 |  |  | $ | (8,605) |
Patents | 481 |  |  | (380) |  |  | 481 |  |  | (381) |
Other intangible assets | 2,406 |  |  | (1,643) |  |  | 2,380 |  |  | (1,612) |
Amortizable intangible assets | $ | 17,293 |  |  | $ | (10,821) |  |  | $ | 17,188 |  |  | $ | (10,598) |
Goodwill | $ | 27,240 |  |  | $ | (9,900) |  |  | $ | 26,989 |  |  | $ | (9,900) |
IPR&D | $ | 94 |  |  |  |  | $ | 94 |  |  |
Indefinite-lived intangible assets | $ | 94 |  |  |  |  | $ | 94 |  |  |
The increase in our balance of goodwill is related primarily to our acquisition of Cortex in the first quarter of 2025. The following represents a roll forward of our goodwill balance by reportable segment:
(in millions) | MedSurg |  | Cardiovascular |  |  |  | Total
Balance as of December 31, 2024 | $ | 7,483 |  |  | $ | 9,606 |  |  |  |  | $ | 17,089 |
Goodwill acquired | — |  |  | 205 |  |  |  |  | 205 |
Impact of foreign currency fluctuations and purchase price adjustments | 17 |  |  | 30 |  |  |  |  | 47 |
Balance as of March 31, 2025 | $ | 7,500 |  |  | $ | 9,841 |  |  |  |  | $ | 17,340 |
Goodwill and Other Intangible Asset Impairments We did not record any goodwill or other intangible asset impairment charges in the first quarter of 2025 or 2024. We test our goodwill balances in the second quarter of each year as of April 1 for impairment, or more frequently if impairment indicators are present or changes in circumstances suggest an impairment may exist. Refer to Note A – Significant Accounting Policies to our audited financial statements contained in Item 8. Financial Statements and Supplementary Data of our most recent Annual Report on Form 10-K for further discussion of our annual goodwill and intangible asset impairment testing.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration